WHITNEY HARRIS: Open Payments
NPI 1144409426 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 15 payments from 5 companies in 2025. Trend: 2023 $291 · 2024 $307 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Lilly USA, LLC | 3 | $71 |
| Janssen Pharmaceuticals, Inc | 2 | $61 |
| Amgen Inc. | 3 | $58 |
Products named: LEQVIO, SPRAVATO, Wegovy, MOUNJARO, REPATHA, ZEPBOUND, EVENITY, Ozempic.
Industry payments across CA — which companies pay providers there.
